CNS Drug Discovery and Design Made Smarter

In a recent agreement made with Lundbeck, they will now have access to Logica^®, Charles River and Valo Health's AI platform, to help progress their research into disorders of the nervous system.

Using industry-leading predictive models, chemical design, and synthetic capabilities, Logica's integrated, AI-augmented process translates biological insights into optimized preclinical candidates while reducing the use of research animals.

Through this agreement, Lundbeck will deploy Logica with the aim of creating optimized small molecules that lead to novel therapies for neurological research.

Read the Press Release